XML 36 R27.htm IDEA: XBRL DOCUMENT v3.23.1
Business Combinations (Tables)
 3 Months Ended
Mar. 31, 2023
Business Acquisition [Line Items]  
Schedule of Fair Value of Contingent Consideration Liability

The following table shows the Insight Merger Date contractual payment amounts, as applicable, and the corresponding fair value of each respective Contingent Consideration liability (in thousands):

 

Schedule of Fair Value of Contingent Consideration Liability

       Fair 
   Contractual   Value on the 
   Value   Merger Date 
Milestone 1  $1,500   $1,340 
Milestone 2   3,000    1,830 
Milestone 3 (a)   1,500    770 
Royalty 1 (b)   See(b)     5,980 
Royalty 2 (b)   See(b)     1,210 
Total  $6,000   $11,130 

 

(a) Indicates the maximum payable if the Milestone is achieved.
   
(b) As defined, Royalty Payments are based on a percentage of future revenues of DetermaIO and Pharma Services over their respective useful life, accordingly there is no fixed contractual value for the Royalty Contingent Consideration.
Insight Merger [Member]  
Business Acquisition [Line Items]  
Schedule of Contingent Consideration, Measured at Fair Value

The following tables reflect the activity for Oncocyte’s Contingent Consideration for the three months ended March 31, 2023 and 2022, measured at fair value using Level 3 inputs (in thousands):

 

 Schedule of Contingent Consideration, Measured at Fair Value

   Fair Value 
Balance at December 31, 2021  $7,060 
Change in estimated fair value   360 
Balance at March 31, 2022  $7,420 

 

   Fair Value 
Balance at December 31, 2022  $5,370 
Change in estimated fair value   (2,220)
Balance at March 31, 2023  $3,150 
Chronix Merger [Member]  
Business Acquisition [Line Items]  
Schedule of Contingent Consideration, Measured at Fair Value

The following tables reflect the activity for Oncocyte’s Contingent Consideration for the three months ended March 31, 2023 and March 31, 2022, measured at fair value using Level 3 inputs (in thousands):

 

Schedule of Contingent Consideration, Measured at Fair Value

   Fair Value 
Balance at December 31, 2021  $69,621 
Change in estimated fair value   (5,016)
Balance at March 31, 2022  $64,605 

 

   Fair Value 
Balance at December 31, 2022  $40,292 
Change in estimated fair value   (16,087)
Balance at March 31, 2023  $24,205